All lobbying filings

HIV and Hepatitis Policy Institute

HIV and Hepatitis Policy Institute filed a Q4 report for HIV and Hepatitis Policy Institute on January 20, 2026.

Lobbying for HIV and Hepatitis Policy Institute · Patient advocacy

As filed: HIV AND HEPATITIS POLICY INSTITUTE for HIV AND HEPATITIS POLICY INSTITUTE.

All filings by HIV and Hepatitis Policy Institute · Everything HIV and Hepatitis Policy Institute has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Expenses

$40,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 10

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Budget/Appropriations

CDC domestic HIV and hepatitis prevention, Ryan White HIV/AIDS Program, Ending the HIV Epidemic Initiative, including PrEP activities for community health centers, Minority AIDS Initiative, and NIH AIDS research

Health Issues

Ending the HIV Epidemic initiative, PrEP coverage, CDC HIV Prevention Programs, Ryan White HIV/AIDS Program, Community Health Centers PrEP Program

Insurance

Preventive Service insurance coverage for PrEP, Copay Assistance & Cost sharing for prescription drugs, Essential Health Benefits & Prescription Drugs

Pharmacy

Preventive Service coverage for PrEP, Copay Assistance & Cost sharing for prescription drugs; Essential Health Benefits & Prescription Drugs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.